Ankylosing spondylitis in West Africans - evidence for a non-HLA-B27 protective effect

Annals of the Rheumatic Diseases

Volumn 56, Issue 1, 1997, Pages 68-70

  Brown, M A ^a   Jepson, A ^a   Young, A ^a   Whittle, H C ^b   Greenwood, B M ^b   Wordsworth, B P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; FEMALE; GAMBIA; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; TWINS;

EID: 0031019845     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.1.68     Document Type: Article

References (13)

1. Khan M. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 1995;7:263-9.
2. McMichael A, Bell J. HLA B27: a disease-associated immune response gene. Res Immunol 1991;142:475-82.
3. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Greenwood BM, McMichael AJ. HLA class I typing by PCR: HLA-B27 and an African B27 subtype [see comments]. Lancet 1991;337:640-2.
4. Colbert RA, Rowland-Jones SL, McMichael AJ, Frelinger JA. Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B *2703. Immunity 1994;1:121-30.
5. Lopez-Larrea C, Sujirachato K, Mehra NK, Chiewslip P, Isarangkura D, Kanga U, et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 1995;45:169-76.
6. Allsopp CE, Harding RM, Taylor C, Bunce M, Kwaitowski D, Anstey N, et al. Interethnic genetic differentiation in Africa: HLA class I antigens in The Gambia. Am J Hum Genet 1992;50:411-21.
7. Jepson AP, Banya WA, Sisay-Joof F, Hassan-King M, Bennett S, Whittle HC: Genetic regulation of fever in Plasmodium falciparum malaria in Gambian twin children. J Infect Dis. 1995;172:316-9.
8. Dougados M, van der Linden S, Juhlin F, Huitfield B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
9. Iitia A, Hogdall E, Dahlen P, Huskainen P, Vuust J, Siitari H. Detection of mutation delta F508 in the cystic fibrosis gene using allele-specific PCR primers and time-resolved fluorimetry. PCR Methods Appl 1992:157-62.
10. Brown MA, Pile KD, Kennedy LG, Calin A, Darke C, Bell J, et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996;55:268-70.
11. Gran J, Husby G, Hordvik M. Prevalence of ankylosing spondylitis in males and females in a young middle aged population in Tromso, northern Norway. Ann Rheum Dis 1985;44:359-67.
12. Khan M, Braun W, Jushner I, Grecek DE, Muir WA, Steiberg AG. HLA B27 in ankylosing spondylitis: differences in frequency and relative risk in American blacks and caucasians. J Rheumatol 1977;4(suppl 3):39-43.
13. Breur-Vriesendorp BS, Dekker-Saeys AJ, Ivanyi P. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules. Ann Rheum Dis 1987;46:353-6.